以下属于生化通路的组成部分的是？? the end product 终产物|enzymes 酶|intermediates 中间产物|所有选项均正确

AU2010209650 (A1) Key intermediates for the synthesis of Rosuvastatin or pharmaceutically acceptable salts thereof . Inventor(s): ZDENKO CASAR; JANEZ KOSMRLJ + (CASAR, ZDENKO, ; KOSMRLJ, JANEZ) Applicant(s): LEK PHARMACEUTICALS + (LEK PHARMACEUTICALS D.D) Classification: - international: A61K31/505; A61P3/06; C07D239/42 - European: C07D239/42 从上述信息判断该文献的文献类型为：

AU2010209650 (A1) Key intermediates for the synthesis of Rosuvastatin or pharmaceutically acceptable salts thereof . Inventor(s): ZDENKO CASAR JANEZ KOSMRLJ (CASAR, ZDENKO, KOSMRLJ, JANEZ) Applicant(s): LEK PHARMACEUTICALS (LEK PHARMACEUTICALS D.D) Classification: - international: A61K31/505 A61P3/06 C07D239/42 - European: C07D239/42 从上述信息判断该文献的文献类型为：

中国大学MOOC: AU2010209650 (A1) Key intermediates for the synthesis of Rosuvastatin or pharmaceutically acceptable salts thereof . Inventor(s): ZDENKO CASAR; JANEZ KOSMRLJ + (CASAR, ZDENKO, ; KOSMRLJ, JANEZ) Applicant(s): LEK PHARMACEUTICALS + (LEK PHARMACEUTICALS D.D) Classification: - international: A61K31/505; A61P3/06; C07D239/42 - European: C07D239/42 从上述信息判断该文献的文献类型为：